Pediatric Allergy Asthma News

Significant disparities exist between patients with peanut allergies who are currently receiving oral immunotherapy and those who are not, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Young children who experience more infections such as colds and pneumonia face greater risk for developing asthma later in childhood, according to a study published in The Journal of Allergy, Asthma and Clinical Immunology: In Practice.

SAN DIEGO — Nasal sampling revealed three asthma endotypes among minoritized youth that could be potential targets for treatment, according to an abstract presented at the American Thoracic Society International Conference.

Modified criteria that incorporated symptoms specific to infants and young children increased identification of anaphylaxis in these age groups, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Asthma exacerbations among Navajo Nation children occur frequently, with over half of those with asthma reporting hospitalizations or urgent care visits, according to a study published in The Journal of Allergy and Immunology: In Practice.

Families of children with peanut allergies that pursued oral immunotherapy cited remission and the potential for disease modification as their reason, according to a study published in The Journal of Allergy and Immunology: In Practice.

Gut microbiomes in children with food allergy may differ from those without food allergy, with fewer differences seen in younger children, according to a study published in Annals of Allergy, Asthma and Immunology.

The FDA has approved Zoryve cream 0.15% for the treatment of mild to moderate atopic dermatitis in adult and pediatric patients aged 6 years and older, Arcutis announced in a press release.

Dupilumab treatment was associated with the reduced risk for atopic march progression in pediatric and adolescent patients with atopic dermatitis, according to a study.

Participants with an allergy to cow’s milk had the lowest rate of oral immunotherapy treatment discontinuation, according to a study published in Annals of Allergy, Asthma and Immunology.